Skip to content
Disclosery

Alerce Investment Management, L.P.

Follow

13F filer, CIK 1844002, Chicago, IL

Alerce Investment Management, L.P. reported $56,800,164 across 5 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000895345-25-000069

Period
2024-12-31
Reported value
$56.8M
Holdings
5
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
VERONA PHARMA PLCreduced-117,880-$5.47M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2024

Share positions as resolved from 13F-HR 0000895345-25-000069, largest first. % of portfolio is the value over $56,800,164, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: 7,056,024 shares; 2023Q2: 7,056,024 shares; 2023Q3: 7,056,024 shares; 2023Q4: 7,406,024 shares; 2024Q1: 7,406,024 shares; 2024Q2: 7,406,024 shares; 2024Q3: 7,406,024 shares; 2024Q4: 7,406,024 shares 7,406,024$38M66.89%0Timeline
AKBAAKEBIA THREAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: 16,205,119 shares; 2023Q2: 16,205,119 shares; 2023Q3: 16,205,119 shares; 2023Q4: 16,205,119 shares; 2024Q1: 13,205,119 shares; 2024Q2: 5,747,906 shares; 2024Q3: 5,747,906 shares; 2024Q4: 5,747,906 shares 5,747,906$10.9M19.23%0Timeline
VERONA PHARMA PLCVERONA PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 213,000 shares; 2024Q3: 205,880 shares; 2024Q4: 88,000 shares 88,000$4.09M7.19%-117,880
AMWLAMERICAN WELL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 523,785 shares; 2024Q4: 523,785 shares 523,785$3.8M6.69%0Timeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: 1,630,830 shares; 2023Q2: 1,630,830 shares; 2023Q3: 1,630,830 shares; 2023Q4: 1,630,830 shares; 2024Q1: 1,630,830 shares; 2024Q2: 1,630,830 shares; 2024Q3: 659 shares; 2024Q4: 659 shares 659$2.08K<0.01%0Timeline

How Q4 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000895345-25-000069 base2025-02-14acceptance time not in the bulk data set